Genedrive scores US army coup with DNA-testing deal

UK group to supply kits to detect biological warfare agents The FT reports that Genedrive has clinched a rare deal with the US armed forces, providing them with millions of pounds of kit to test for biological warfare agents. The … Continued

Calculus Capital invests £3m in Origin Broadband

Private equity fund manager and Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £3m in Origin Broadband, an award-winning provider of internet and phone services. Since launch in 2011, Origin has developed its own infrastructure … Continued

Calculus Capital invests £3m in Weedingtech

Calculus Capital has invested £3m in cleantech firm Weedingtech, which is focused on replacing toxic herbicides. Weedingtech is a world leader in herbicide-free weed and moss control, and has earned multiple awards for sustainable innovation. The company was co-founded by … Continued

Synpromics announces a research collaboration with GE Healthcare

Calculus Capital’s portfolio company Synpromics, the leading synthetic promoter and gene control company, announced a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will develop a complex bar-coded library … Continued